By Jeffrey Bouley

Daré Bioscience goes after bacterial vaginosis

Company announces publication of DARE-BV1 proof-of-concept study for proprietary thermosetting hydrogel formulation of clindamycin phosphate for one-time vaginal administration
Subscribe to Newsletter
Subscribe to our eNewsletters

Stay connected with all of the latest from Drug Discovery News.

DDN Magazine May 2024

Latest Issue  

• Volume 20 • Issue 3 • May 2024

May 2024

May 2024 Issue